Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

MDSAP Explained: A Pure Global Guide to Participating Countries for MedTech & IVD Market Access

3:49
 
Share
 

Manage episode 517321284 series 3684506
Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode of MedTech Global Insights, we explore the Medical Device Single Audit Program (MDSAP), a revolutionary framework allowing MedTech and IVD manufacturers to satisfy the quality management system requirements of multiple countries through a single audit. We break down how this program can dramatically reduce audit fatigue and accelerate time-to-market. We detail the five core member countries—Australia, Brazil, Canada, Japan, and the U.S.—and explain the unique role MDSAP plays in each jurisdiction, from being a mandatory requirement in Canada to a substitute for routine FDA inspections. We also uncover the program's growing global influence by discussing the key official observers like the EU and affiliate members like South Korea and Mexico, who leverage MDSAP reports for their own regulatory needs. Consider this scenario: you are a MedTech scale-up planning to launch your device in the U.S., Canada, and Brazil. You're facing the daunting and expensive task of preparing for three separate quality system audits, each with its own timeline and complexities. How can you consolidate this process, save critical resources, and streamline your entry into these key markets with a single, unified audit? Key Takeaways: * Which five regulatory authorities form the core of the MDSAP consortium? * Why is MDSAP certification a mandatory requirement for market access in Canada? * How does the U.S. FDA leverage MDSAP reports within its own inspection program? * What is the official role of the European Union and the World Health Organization in the MDSAP? * Which fast-growing markets in Asia and Latin America are now officially recognizing MDSAP audit reports? * Can a single audit truly satisfy the distinct regulatory requirements of Brazil's ANVISA and Japan's PMDA? * What are the primary strategic benefits that drive companies to invest in MDSAP certification? * How can an MDSAP audit accelerate your product launch timeline in multiple countries simultaneously? Contact us for more information at [email protected] or visit https://pureglobal.com/.
  continue reading

89 episodes

Artwork
iconShare
 
Manage episode 517321284 series 3684506
Content provided by Ran Chen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ran Chen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode of MedTech Global Insights, we explore the Medical Device Single Audit Program (MDSAP), a revolutionary framework allowing MedTech and IVD manufacturers to satisfy the quality management system requirements of multiple countries through a single audit. We break down how this program can dramatically reduce audit fatigue and accelerate time-to-market. We detail the five core member countries—Australia, Brazil, Canada, Japan, and the U.S.—and explain the unique role MDSAP plays in each jurisdiction, from being a mandatory requirement in Canada to a substitute for routine FDA inspections. We also uncover the program's growing global influence by discussing the key official observers like the EU and affiliate members like South Korea and Mexico, who leverage MDSAP reports for their own regulatory needs. Consider this scenario: you are a MedTech scale-up planning to launch your device in the U.S., Canada, and Brazil. You're facing the daunting and expensive task of preparing for three separate quality system audits, each with its own timeline and complexities. How can you consolidate this process, save critical resources, and streamline your entry into these key markets with a single, unified audit? Key Takeaways: * Which five regulatory authorities form the core of the MDSAP consortium? * Why is MDSAP certification a mandatory requirement for market access in Canada? * How does the U.S. FDA leverage MDSAP reports within its own inspection program? * What is the official role of the European Union and the World Health Organization in the MDSAP? * Which fast-growing markets in Asia and Latin America are now officially recognizing MDSAP audit reports? * Can a single audit truly satisfy the distinct regulatory requirements of Brazil's ANVISA and Japan's PMDA? * What are the primary strategic benefits that drive companies to invest in MDSAP certification? * How can an MDSAP audit accelerate your product launch timeline in multiple countries simultaneously? Contact us for more information at [email protected] or visit https://pureglobal.com/.
  continue reading

89 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play